D.D. Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 17-07-2024
- Paid Up Capital ₹ 3.60 M
as on 17-07-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.98 Cr
as on 17-07-2024
- Satisfied Charges ₹ 29.42 Cr
as on 17-07-2024
- Revenue 27.31%
(FY 2023)
- Profit 34.97%
(FY 2023)
- Ebitda 25.79%
(FY 2023)
- Net Worth 12.02%
(FY 2023)
- Total Assets 7.18%
(FY 2023)
About D.D. Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.60 M.
The company currently has active open charges totaling ₹14.98 Cr. The company has closed loans amounting to ₹29.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alka Choudhary, Amit Choudhary, and Lalita Choudhary serve as directors at the Company.
- CIN/LLPIN
U24232RJ1994PTC008661
- Company No.
008661
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Sitapura,Tonk Road,Jaipur., Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at D.D. Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alka Choudhary  | Whole-Time Director | 10-Mar-2014 | Current |
| Amit Choudhary | Whole-Time Director | 22-Jun-2001 | Current |
| Lalita Choudhary | Whole-Time Director | 12-Aug-1994 | Current |
Financial Performance of D.D. Pharmaceuticals.
D.D. Pharmaceuticals Pvt. Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 27.31% increase. The company also saw a substantial improvement in profitability, with a 34.97% increase in profit. The company's net worth Soared by an impressive increase of 12.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D.D. Pharmaceuticals?
In 2023, D.D. Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarvam Global Healthcare LlpActive 9 years 2 monthsAlka Choudhary and Amit Choudhary are mutual person
- Prakash Mental Care And Services Private LimitedActive 6 years 6 months
Amit Choudhary is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Feb 2022 | ₹4.48 M | Open |
Others Creation Date: 15 Dec 2021 | ₹6.50 M | Open |
Others Creation Date: 27 Jul 2021 | ₹6.75 M | Open |
How Many Employees Work at D.D. Pharmaceuticals?
D.D. Pharmaceuticals has a workforce of 252 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D.D. Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D.D. Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
